Effect of hyperosmotic solutions on human brain tumour vasculature

Acta Neurochirurgica

Volumn 140, Issue 11, 1998, Pages 1135-1142

  Sato, S ^a,c   Kawase, T ^a   Harada, S ^a   Takayama, H ^b   Suga, S ^a  

^a KEIO UNIVERSITY   (Japan)

^b Institute of Brain and Blood Vessels   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood brain barrier; Metastatic brain tumour; Microcirculation; Tumour vasculature

Indexed keywords

FLUORESCEIN; MANNITOL;

ARTICLE; ASTROCYTOMA; BLOOD BRAIN BARRIER; BRAIN METASTASIS; BRAIN TUMOR; CASE REPORT; CLINICAL FEATURE; FLUORESCENCE ANGIOGRAPHY; GLIOBLASTOMA; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ASTROCYTOMA; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CEREBRAL ANGIOGRAPHY; FLUORESCEIN ANGIOGRAPHY; GLIOBLASTOMA; HUMANS; HYPERTONIC SOLUTIONS; MANNITOL; MICROCIRCULATION;

EID: 0031758418     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007010050227     Document Type: Article

References (39)

1. Anton R, Kordower JH, Maidment NT, Manaster JS, Kane DJ, Rabizadeh S, Schueller SB, Yang J, Rabizadeh S, Edwards RH, et al (1994) Neural-targeted gene therapy for rodent and primate hemiparkinsonism. Exp Neurol 127: 207-218
2. Barna BP, Rogers LR, Thomassen MJ, Barnett GH, Estes ML (1991) Monocyte tumoricidal activity and tumor necrosis factor production in patients with malignant brain tumors. Cancer Immunol Immunother 33: 314-318
3. Beck DW, Dunbar EC, Poor MM Jr (1990) Glioma cell influence on cerebral endothelial cell Na(+)-K(+)-ATPase. Adv Neurol 52: 415-420
4. Brightman MW, Hori M, Rapoport SI, Reese TS, Westergaard E (1973) Osmotic opening of tight junctions in cerebral endothelium. J Comp Neurol 152: 317-325
5. Culver KW, Van Gilder J, Link CJ, Carlstrom T, Buroker T, Yuh W, Koch K, Schabold K, Doornbas S, Wetjen B, et al (1994) Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum Gene Ther 5: 343-379
6. Doran SE, Ren XD Betz AL, Pagel MA, Neuwelt EA, Roessler BJ, Davidson BL (1995) Gene expression from recombinant viral vectors in the central nervous system after blood-barin barrier disruption. Neurosurgery 36: 965-970
7. Hasegawa H, Ushio Y, Hayakawa T, Yamada K, Mogami H (1983) Changes of the blood-brain barrier in experimental metastatic brain tumors. J Neurosurg 59: 304-310
8. Houthoff HJ, Go KG, Gerrits PO (1982) The mechanisms of blood-brain barrier impairment by hyperosmolar perfusion. An electron cytochemical study comparing exogenous HRP and endogenous antibody to HRP as tracers. Acta Neuropathol (Berl) 56: 99-112
9. Klatzo I (1967) Presidential address. Neuropathological aspects of brain edema. J Neuropathol Exp Neurol 26: 1-14
10. Lesser GJ, Grossman SA (1993) The chemotherapy of adult primary brain tumors. Cancer Treat Rev 19: 261-281
11. Neuwelt EA, Balaban E, Diehl J, Hill S, Frenkel E (1983) Successful treatment of primary central nervous system lymphomas with chemotherapy after osmotic blood-brain barrier opening. Neurosurgery 12: 662-671
12. Neuwelt EA, Barnett PA, Hellstrom KE, Hellstrom I, McCormick CI, Ramsey FL (1994) Effect of blood-brain barrier disruption on intact and fragmented monoclonal antibody localization in intracerebral lung carcinoma xenografts. J Nucl Med 35: 1831-1841
13. Neuwelt EA, Barnett PA, McCormick CI, Frenkel EP, Minna JD (1985) Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain. Neurosurgery 17: 419-423
14. Neuwelt EA, Dahlborg SA (1987) Chemotherapy administered in conjunction with osmotic blood-brain barrier modification in patients with brain metastases. J Neurooncol 4: 195-207
15. Neuwelt EA, Diehl JT, Vu LH, Hill SA, Michael AJ, Frenkel EP (1981) Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption. Ann Intern Med 94: 449-454
16. Neuwelt EA, Frenkel EP, Rapoport S, Barnett P (1980) Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog. Neurosurgery 7: 36-43
17. Neuwelt EA, Horaczek A, Pagel MA (1990) The effect of steroids on gentamicin delivery to brain after blood-brain barrier disruption. J Neurosurg 72: 123-126
18. Neuwelt EA, Maravilla KR, Frenkel EP, Barnett P, Hill S, Moore RJ (1980) Use of enhanced computerized tomography to evaluate osmotic blood-brain barrier disruption. Neurosurgery 6: 49-56
19. Neuwelt EA, Maravilla KR, Frenkel EP, Rapaport SI, Hill SA, Barnett PA (1979) Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery. J Clin Invest 64: 684-688
20. Neuwelt EA, Minna J, Frenkel E, Barnett PA, McCormick CI (1986) Osmotic blood-brain barrier opening to IgM monoclonal antibody in the rat. Am J Physiol 250: R875-R883
21. Neuwelt EA, Pagel MA, Dix RD (1991) Delivery of ultraviolet-inactivate 35S-herpesvirus across an osmotically modified blood-brain barrier. J Neurosurg 74: 475-479
22. Neuwelt EA, Rapoport SI (1984) Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. Fed Proc 43: 214-219
23. Neuwelt EA, Specht HD, Barnett PA, Dahlborg SA, Miley A, Larson SM, Brown P, Eckerman KF, Hellstrom KE, Hellstrom I (1987) Increased delivery of tumor-specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous system. Neurosurgery 20: 885-895
24. Neuwelt EA, Specht HD, Howieson J, Haines JE, Bennett MJ, Hill SA, Frenkel EP (1983) Osmotic blood-brain barrier modification: clinical documentation by enhanced CT scanning and/ or radionuclide brain scanning. AJR Am J Roentgenol 141: 829-835
25. Neuwelt EA, Weissleder R, Nilaver G, Kroll RA, Roman-Goldstein S, Szumowski J, Pagel MA, Jones RS, Remsen LG, McCormick CI, et al (1994) Delivery of virus-sized iron oxide particles to rodent CNS neurons. Neurosurgery 34: 777-784
26. Neuwelt EA, Wiliams PC, Mickey BE, Frenkel EP, Henner WD (1994) Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood-brain barrier disruption. Pediatr Neurosurg 21: 16-22
27. Nilaver G, Muldoon LL, Kroll RA, Pagel MA, Breakefield XO, Davidson BL, Neuwelt EA (1995) Delivery of herpesvirus and adenovirus to under rat intracerebral tumors after osmotic blood-brain barrier disruption. Proc Natl Acad Sci USA 92: 9829-9833
28. Nishihara K (1989) A novel experimental approach to immunotherapy against malignant brain tumor with the mouse IFN-gamma gene transfer. Nippon Geka Hokan 58: 18-42
29. Rapoport SI, Bachman DS, Thompson HK (1972) Chronic effects of osmotic opening of the blood-brain barrier in the monkey. Science 176: 1243-1245
30. Rapoport SI, Hori M, Klatzo I (1971) Reversible osmotic opening of the blood-brain barrier. Science 173: 1026-1028
31. Rapoport SI, Hori M, Klatzo I (1972) Testing of a hypothesis for osmotic opening of the blood-brain barrier. Am J Physiol 223: 323-331
32. Rapoport SI, Matthews K, Thompson HK, Pettigrew KD (1977) Osmotic opening of the blood-brain barrier in the rhesus monkey without measurable brain edema. Brain Res 136: 23-29
33. Rapoport SI, Ohno K, Fredericks WR, Pettigrew KD (1978) Regional cerebrovascular permeability to (14C) sucrose after osmotic opening of the blood-brain barrier. Brain Res 150: 653-657
34. Rapoport SI, Robinson PJ (1986) Tight-junctional modification as the basis of osmotic opening of the blood-brain barrier. Ann NY Acad Sci 481: 250-267
35. Roman-Goldstein S, Clunie DA, Stevens J, Hogan R, Monard J, Ramsey F, Neuwelt EA (1994) Osmotic blood-brain barrier disruption: CT and radionuclide imaging. AJNR Am J Neuroradiol 15: 581-590
36. Roman-Goldstein S, Mitchell P, Crossen JR, Williams PC, Tindall A, Neuwelt EA (1995) MR and cognitive testing of patients undergoing osmotic blood-brain barrier disruption with intraarterial chemotherapy. AJNR Am J Neuroradiol 16: 543-553
37. Roman-Goldstein SM, Barnett PA, McCormick CI, Ball MJ, Ramsey F, Neuwelt EA (1991) Effects of gadopectetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findings. AJNR Am J Neuroradiol 12: 885-890
38. Roman-Goldstein SM, Barnett PA, McCormick CI, Szumowski J, Shannon EM, Ramsey FL, Mass M, Neuwelt EA (1994) Effects of Gd-DTPA after osmotic BBB disruption in a rodent mode: toxicity and MR findings. J Comput Assist Tomogr 18: 731-736
39. Sato S, Suga S, Yunoki K, Mihara B (1994) Effect of barrier opening on brain edema in human brain tumors. Acta Neurochir [Suppl] (Wien) 60: 116-118